Published in Med Sci Monit on November 26, 2013
Serum and synovial fluid levels of CCL18 are correlated with radiographic grading of knee osteoarthritis. Med Sci Monit (2015) 0.78
The role of the arginine metabolome in pain: implications for sickle cell disease. J Pain Res (2016) 0.76
Serum and synovial fluid nesfatin-1 concentration is associated with radiographic severity of knee osteoarthritis. Med Sci Monit (2015) 0.75
The L-arginine-nitric oxide pathway. N Engl J Med (1993) 14.38
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet (1992) 5.36
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest (1998) 3.34
Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem (1998) 2.92
Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation (2001) 2.59
Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey. Am J Manag Care (2002) 2.33
The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage (2003) 2.27
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res (2005) 2.24
Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation (1999) 2.14
Osteoarthritis in the carpometacarpal joint of the thumb. Prevalence and associations with disability and mortality. J Bone Joint Surg Am (2004) 1.94
Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthritis Cartilage (2005) 1.93
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis. Nephrol Dial Transplant (2006) 1.90
Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide (1997) 1.85
TBARS and cardiovascular disease in a population-based sample. J Cardiovasc Risk (2001) 1.81
Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol (2000) 1.72
The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ther (2007) 1.59
Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev (2003) 1.57
Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol (2007) 1.53
Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens (1998) 1.51
Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett (2000) 1.29
Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int (1997) 1.28
Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol (2004) 1.22
Decreased survival with increasing prevalence of full-body, radiographically defined osteoarthritis in women. Am J Epidemiol (1995) 1.20
Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem (2010) 1.19
Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Atherosclerosis (2008) 1.13
Reactive nitrogen and oxygen species in interleukin-1-mediated DNA damage associated with osteoarthritis. Osteoarthritis Cartilage (2007) 1.12
Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int (2006) 1.12
Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction. Arterioscler Thromb Vasc Biol (2008) 1.10
Osteoarthritis and nitric oxide. Osteoarthritis Cartilage (2008) 1.06
A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS). A comparison with a commercially available kit. Clin Biochem (2006) 1.01
Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule. Med Sci Monit (2009) 1.01
Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: an epidemiological study. Atherosclerosis (2006) 0.97
The presence of molecular markers of in vivo lipid peroxidation in osteoarthritic cartilage: a pathogenic role in osteoarthritis. Arthritis Rheum (2005) 0.93
Osteoarthritis as a determinant of an adverse coronary heart disease risk profile. J Cardiovasc Risk (1996) 0.92
Type II collagen peptides for measuring cartilage degradation. Biorheology (2004) 0.91
Endothelial function and left ventricular remodeling in diabetic and non-diabetic patients after acute coronary syndrome. Med Sci Monit (2011) 0.89
Endothelial nitric oxide synthase deficiency in mice results in reduced chondrocyte proliferation and endochondral bone growth. Arthritis Rheum (2010) 0.87
Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC. Methods Mol Med (2005) 0.84
Co-morbidities of patients with knee osteoarthritis. Hong Kong Med J (2009) 0.81
Assessment of paraoxonase activities in patients with knee osteoarthritis. Redox Rep (2008) 0.80
Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography. Coron Artery Dis (2006) 0.79
L-Arginine is related to endothelium-dependent vasodilation in resistance and conduit arteries in divergent ways-The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis (2008) 0.77
Paraoxonase-1 activity and oxidative status in patients with knee osteoarthritis and their relationship with radiological and clinical parameters. Scand J Clin Lab Invest (2012) 0.77
The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation. Med Sci Monit (2011) 0.76
Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study. Arthritis Care Res (Hoboken) (2013) 2.04
Result of arthroscopic treatment of pigmented villonodular synovitis of the knee. Arthroscopy (2003) 1.19
Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev (2008) 1.05
Increased tumor necrosis factor-alpha and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: the effects of analgesic drugs. Anesth Analg (2007) 1.03
Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule. Med Sci Monit (2009) 1.01
Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology (Oxford) (2009) 0.96
The management of sacral stress fractures: current concepts. Clin Cases Miner Bone Metab (2011) 0.95
Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain. Eur J Pain (2007) 0.90
Adhesive capsulitis of the shoulder in human immunodeficiency virus-positive patients during highly active antiretroviral therapy. J Shoulder Elbow Surg (2006) 0.90
The Genesis II in primary total knee replacement: a systematic literature review of clinical outcomes. Knee (2011) 0.87
Extracorporeal shock wave therapy in musculoskeletal disorders: a review. Med Princ Pract (2013) 0.85
Arthroscopic treatment for greater tuberosity fractures: rationale and surgical technique. Arthroscopy (2004) 0.85
Nitric oxide and prostacyclin pathways: an integrated mechanism that limits myocardial infarction progression in anaesthetized rats. Pharmacol Res (2006) 0.85
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol (2005) 0.84
In vivo and in vitro effects of bromelain on PGE(2) and SP concentrations in the inflammatory exudate in rats. Pharmacology (2002) 0.84
Increased substance P and tumor necrosis factor-alpha level in the paws following formalin injection in rat tail. Brain Res (2004) 0.83
Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats. Eur J Pharmacol (2006) 0.83
Robotic treadmill training improves cardiovascular function in spinal cord injury patients. Int J Cardiol (2010) 0.82
A catastrophic complication of hip arthroscopy. Arthroscopy (2011) 0.82
Pelvic parameters and global spine balance for spine degenerative disease: the importance of containing for the well being of content. Eur Spine J (2014) 0.81
Does primary or secondary chondrocalcinosis influence long-term survivorship of unicompartmental arthroplasty? Clin Orthop Relat Res (2011) 0.81
Survivorship at minimum 10-year follow-up of a rotating-platform, mobile-bearing, posterior-stabilised total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc (2014) 0.81
The heart in rheumatoid arthritis. Autoimmun Rev (2009) 0.80
Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis. J Rheumatol (2011) 0.80
Value of digital telethermography for the diagnosis of septic knee prosthesis: a prospective cohort study. BMC Musculoskelet Disord (2013) 0.79
Effectiveness of extracorporeal shock wave therapy in bone marrow edema syndrome of the hip. Rheumatol Int (2014) 0.79
Shoulder disorders in female working-age population: a cross sectional study. BMC Musculoskelet Disord (2014) 0.79
Custom-made articulating spacer in two-stage revision total knee arthroplasty. An early follow-up of 14 cases of at least 1 year after surgery. HSS J (2007) 0.78
Radiofrequency-based plasma microtenotomy compared with arthroscopic subacromial decompression yields equivalent outcomes for rotator cuff tendinosis. Arthroscopy (2007) 0.77
Characterization of articular chondrocytes isolated from 211 osteoarthritic patients. Cell Tissue Bank (2013) 0.76
Arthroscopic rotator interval repair: the three-step all-inside technique. Arthroscopy (2004) 0.76
Repair of osteochondral defects in the minipig model by OPF hydrogel loaded with adipose-derived mesenchymal stem cells. Regen Med (2015) 0.75
A bizarre complication of shoulder arthroscopy. Knee Surg Sports Traumatol Arthrosc (2013) 0.75
Extracorporeal Shock Wave Therapy is effective in the treatment of bone marrow edema of the medial compartment of the knee: a comparative study. Med Princ Pract (2016) 0.75
Cardiovascular injury in systemic autoimmune diseases: an update. Intern Emerg Med (2011) 0.75
Effectiveness of ESWT in the treatment of Kienböck's disease. Ultrasound Med Biol (2011) 0.75
Results of distal metatarsal osteotomy using absorbable pin fixation. Foot Ankle Int (2009) 0.75
Chevron osteotomy of the first metatarsal stabilized with an absorbable pin: our 5-year experience. Foot Ankle Int (2013) 0.75